CARLSMED, INC. 8-K

What Happened
Carlsmed, Inc. announced the voting results from its 2026 Annual Meeting of Stockholders held on June 3, 2026 (filed on Form 8-K, Item 5.07). Stockholders elected two Class I directors and ratified the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The report was signed by CEO Michael Cordonnier.

Key Details

• Directors elected (terms ending at the 2029 annual meeting):
  • Niall Casey — For: 19,627,716; Withheld: 1,352,117; Broker non-votes: 4,628,080.
  • Philip Young — For: 19,510,686; Withheld: 1,469,147; Broker non-votes: 4,628,080.
• Auditor ratification: Ernst & Young LLP — For: 25,571,065; Against: 5,858; Abstentions: 30,990.
• The proxy statement describing these proposals was previously filed on Schedule 14A on April 22, 2026.

Why It Matters
Board elections and auditor ratification are routine but material governance events. Re-election of directors confirms leadership continuity through 2029, and ratifying Ernst & Young LLP confirms the firm that will audit Carlsmed’s financial statements for 2026 — information investors use to assess governance and the reliability of upcoming financial reports.